Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Suzu Yae"'
Autor:
Kunihiko Minakata, Hiroyuki Moriyama, Muneaki Hashimoto, Kuniaki Seyama, Takeshi Nara, Kazuto Nishio, Fumiyuki Takahashi, Kazuhisa Takahashi, Suzu Yae, Fariz Nurwidya, Fumiaki Koizumi, Akiko Murakami, Ken Tajima
Publikováno v:
Cancer Sci
Somatic mutations in the epidermal growth factor receptor (EGFR) gene, such as exon 19 deletion mutations, are important factors in determining therapeutic responses to gefitinib in non‐small‐cell lung cancer (NSCLC). However, some patients have
Publikováno v:
Juntendo Medical Journal. 58:506-511
Autor:
Yasuhiro Mizuno, Suzu Yae, Chiaki Kawanishi, Motonori Sairenji, Masanari Onose, Shigeko Okuno, Hideki Onishi
Publikováno v:
Palliative and Supportive Care. 4:87-89
Objective: We report here a terminally ill patient with stomach cancer who developed a brief psychotic disorder mimicking cerebrovascular attack after a short episode of nasal bleeding. Close examination of the patient revealed that nasal bleeding wa
Autor:
Suzu Yae, Hiroyuki Kobayashi, Akiko Murakami, Fariz Nurwidya, Mayumi Tamada, Kunihiko Minakata, Kazuhisa Takahashi, Rika Tsukada, Motoyasu Kato, Kengo Koike, Kuniaki Seyama, Toshifumi Yae, Fumiyuki Takahashi, Momoko Yoshikawa, Takuji Yamaguchi
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2012 (2012)
Evidence-Based Complementary and Alternative Medicine, Vol 2012 (2012)
Cachexia, a major cause of cancer-related death, is characterized by depletion of muscle and fat tissues, anorexia, asthenia, and hypoglycemia. Recent studies indicate that secretions of proinflammatory cytokines such as interleukin-6 (IL-6) play a c
Autor:
Keiko Muraki, Toshifumi Yae, Rina Ohashi, Fumiyuki Takahashi, Fariz Nurwidya, Ken Tajima, Ryo Koyama, Kuniaki Seyama, Suzu Yae, Kunihiko Minakata, Takanori Mori, Takehito Shukuya, Akiko Murakami, Kazuhisa Takahashi
Publikováno v:
C66. MOLECULAR TARGETS FOR THERAPEUTIC DEVELOPMENT IN LUNG CANCER.
Somatic mutations in epidermal growth factor receptor (EGFR) gene, such as exon 19 deletion mutation, are important factors Rationale; to determine therapeutic response to gefitinib in non-small cell lung cancer (NSCLC). However, there are patients w
Publikováno v:
Palliativesupportive care. 3(4)
Malignancy-associated primary thiamine deficiency has been documented in several experimental tumors, clinical case reports, and in patients with fast growing malignancies. We report a terminally ill cancer patient who developed delirium. Close exami
Autor:
Mizuho Ito, Chiaki Kawanishi, Masanari Onose, Hideki Onishi, Yasuhiro Mizuno, Suzu Yae, Shigeko Okuno, Hideyuki Saito
Publikováno v:
Palliativesupportive care. 3(2)
Objective: It is known that families of terminally-ill cancer patients show levels of emotional and functional disruption and are called “second order patients,” however, little is actually known about the health problems of family members, espec